WhichRecall
Class IIReported 2025-01-01

Duloxetine Delayed-Release Capsules, 60 mg, a) 30 count blister cards (NDC 70518-0937-04), b) 30 count bottles (NDC 70518-0937-03), Rx only, Source NDC 57237-0019-99, MFG: Rising Pharma, Inc., Allendale, NJ, Repackaged by: RemedyRepack Inc., Indiana, PA

Recalled by RemedyRepack Inc.

Reason for Recall

CGMP Deviations; presence of N-nitroso-duloxetine impurity above recommended interim limit.

Advertisement
Recall Number
D-0165-2025
Classification
Class II
Status
Ongoing
Category
drug
Initiated
2024-12-02
Reported
2025-01-01
Distribution
Nationwide in the US
Code Info
a) NDC 70518-0937-04, Lot # J0786744-061724, Exp. 06/30/2025 b) NDC 70518-0937-03, Lot # B3002625-060524, Exp. 10/31/2025
Source: openFDA enforcement report. WhichRecall is not affiliated with the FDA. See our disclaimer.
Advertisement